We are live on ! Find out more
EBS icon

Emergent Biosolutions
EBS

168 hedge funds and large institutions have $717M invested in Emergent Biosolutions in 2014 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 57 increasing their positions, 50 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

450% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 8

27% more funds holding

Funds holding: 132 → 168 (+36)

26% more capital invested

Capital invested by funds: $570M → $717M (+$148M)

14% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 50

9.04% more ownership

Funds ownership: 69.27% → 78.3% (+9%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
168
Holders Change
+36
Holders Change %
+27.27%
% of All Funds
4.85%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
44
Increased
57
Reduced
50
Closed
8
Calls
$319K
Puts
–
Net Calls
+$319K
Net Calls Change
-$278K

Top Buyers

Rank Fund Capital Flow
1
BC
Broadfin Capital
New York
+$18.5M
2
NI
Numeric Investors
Massachusetts
+$10.7M
3
State Street
State Street
Massachusetts
+$10.7M
4
GT
Glenmede Trust
Pennsylvania
+$10.5M
5
GAM
Gotham Asset Management
New York
+$6.54M

Top Sellers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
-$25.1M
2
SCA
SAC Capital Advisors
Connecticut
-$12.9M
3
KCM
Kingdon Capital Management
New York
-$7.3M
4
BA
BlackRock Advisors
Delaware
-$4.75M
5
AI
Ariel Investments
Illinois
-$2.82M
Name Holding Trade Value Shares
Change 		Change in
Stake
Canada Life
151
Canada Life
Manitoba, Canada
$38K – – –
Teacher Retirement System of Texas
152
Teacher Retirement System of Texas
Texas
$28K +$152 +6 +0.6%
BlackRock
153
BlackRock
New York
$22K – – –
PNC Financial Services Group
154
PNC Financial Services Group
Pennsylvania
$19K +$2.53K +100 +17%
QT
155
Quantbot Technologies
New York
$17K +$17.7K +700 New
MWP
156
MYCIO Wealth Partners
Pennsylvania
$13K – – –
PCM
157
Prelude Capital Management
New York
$13K +$12.6K +500 New
Manulife (Manufacturers Life Insurance)
158
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$10.3K -$169K -6,672 -2%
EARNEST Partners
159
EARNEST Partners
Georgia
$10K -$5.05K -200 -33%
TWI
160
Thomas White International
Illinois
$10K – – –
Creative Planning
161
Creative Planning
Kansas
$7K – – –
PTC
162
Private Trust Company
Ohio
$3K +$2.75K +109 New
BNP Paribas Financial Markets
163
BNP Paribas Financial Markets
France
$2.24K -$7.91K -313 -79%
TRCT
164
Tower Research Capital (TRC)
New York
$2K -$48.4K -1,918 -96%
EFSCE
165
Enterprise Financial Services Corp (EFSC)
Missouri
$2K +$1.51K +60 New
GAM
166
Gemmer Asset Management
California
$1K +$581 +23 New
Envestnet Asset Management
167
Envestnet Asset Management
Illinois
$1K +$682 +27 New
CCM
168
Consonance Capital Management
New York
– -$25.1M -1,093,828 Closed
AI
169
Ariel Investments
Illinois
– -$2.82M -122,650 Closed
ARTA
170
A.R.T. Advisors
New York
– -$604K -26,281 Closed
PA
171
Profund Advisors
Maryland
– -$343K -14,933 Closed
Jane Street
172
Jane Street
New York
– -$332K -14,430 Closed
CMBA
173
C.M. Bidwell & Associates
Hawaii
– -$127K -5,530 Closed
EWM
174
Elite Wealth Management
Washington
– -$116K -5,055 Closed
HF
175
Hoxton Financial
West Virginia
– -$3K -117 Closed
3 4 5 6
7

EBS Hedge Fund Activity: Q1 2014 in Review

168 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Emergent Biosolutions (EBS) for Q1 2014, worth a combined $717M — up 26% from $570M a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new EBS positions and 8 closed out — a net gain of 36 holders — while 57 added to existing stakes and 50 trimmed.

The largest buyer was Broadfin Capital, adding an estimated $18.5M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $25.1M sold.

  • 168 institutional investors held Emergent Biosolutions (EBS) as of Q1 2014, up from 132 in Q4 2013.
  • Funds reported $717M of Emergent Biosolutions stock for Q1 2014, up 26% quarter-over-quarter.
  • 44 funds opened new Emergent Biosolutions positions in Q1 2014 and 8 closed out, a net change of +36 holders.
  • The largest Emergent Biosolutions buyer in Q1 2014 was Broadfin Capital, an estimated $18.5M added.
  • The largest Emergent Biosolutions seller in Q1 2014 was Consonance Capital Management, an estimated $25.1M sold.

Based on aggregated 13F filings for Q1 2014.